|
Report Date : |
23.02.2013 |
IDENTIFICATION DETAILS
|
Name : |
GEA PHARMA SYSTEMS (INDIA) PRIVATE LIMITED (w.e.f. 07.07.2009) |
|
|
|
|
Formerly Known
As : |
ACO-ENGINEERING ( |
|
|
|
|
Registered
Office : |
Block No.8, Phase B, Village Dumad, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
12.04.2007 |
|
|
|
|
Com. Reg. No.: |
04-050513 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.47.079
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U29249GJ2007FTC050513 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
BRDA02606C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAGCA2753F |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturing of Pharma
Industrial Equipments. |
|
|
|
|
No. of Employees
: |
300 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
B (29) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 700000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Listing : |
-- |
|
|
|
|
Banker’s Note : |
-- |
|
|
|
|
Comments : |
Subject is an established company having moderate track record. The company
is continuously incurring losses from its operations. However, trade
relations are reported as fair. Business is active. Payments are reported to
be slow. The company can be considered for business dealings with some caution.
|
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
INDIAN ECONOMIC OVERVIEW
India is developing into an open-market economy, yet traces of
its past autarkic policies remain. Economic liberalization, including
industrial deregulation, privatization of state-owned enterprises, and reduced
controls on foreign trade and investment, began in the early 1990s and has
served to accelerate the country’s growth, which has averaged more than 7% per
year since 1997. India’s diverse economy encompasses traditional village
farming, modern agriculture, handicrafts, a wide range of modern industries,
and a multitude of services. Slightly more than half of the work force is in
agriculture, but services are the major source of economic growth, accounting
for more than half of India’s output, with only one-third of its labor force.
India has capitalized on its large educated English-speaking population to become
a major exporter of information technology services and software workers. In
2010, the Indian economy rebounded robustly from the global financial crisis –
in large part because of strong domestic demand – and growth exceeded 8%
year-on-year in real terms. However, India’s economic growth in 2011 slowed
because of persistently high inflation and interest rates and little progress
on economic reforms. High international crude prices have exacerbated the
government’s fuel subsidy expenditures contributing to a higher fiscal deficit,
and a worsening current account deficit. Little economic reform took place in
2011 largely due to corruption scandals that have slowed legislative work.
India’s medium-term growth outlook is positive due to a young population and
corresponding low dependency ratio, healthy savings and investment rates, and
increasing integration into the global economy. India has many long-term
challenges that it has not yet fully addressed, including widespread poverty,
inadequate physical and social infrastructure, limited non-agricultural
employment opportunities, scarce access to quality basic and higher education,
and accommodating rural-to-urban migration.
|
Source
: CIA |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION PARTED BY
|
Name : |
Ms. Darshana |
|
Designation : |
Account Executive |
|
Contact No.: |
91-265-3074215 |
|
Date : |
21.02.2013 |
LOCATIONS
|
Registered Office / Factory : |
Block No.8, Phase B, Village Dumad, |
|
Tel. No.: |
91-265-3074272/ 3074202/ 3074203 / 3074206 |
|
Fax No.: |
91-265-3074255 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned |
DIRECTORS
AS ON 25.09.2012
|
Name : |
Mr. Kashyap Upadhyay |
|
Designation : |
Director |
|
Address : |
H-57, Adarsh Duplex, ITI Crossing, Gorwa, Vadodara – 390 016, |
|
Date of Birth/Age : |
20.06.1966 |
|
Date of Appointment : |
20.09.2007 |
|
DIN No.: |
01472012 |
|
|
|
|
Name : |
Mr. Raman Manmohan Madhok |
|
Designation : |
Director |
|
Address : |
1-D, Villa Alto – Monte, |
|
Date of Birth/Age : |
02.02.1945 |
|
Date of Appointment : |
28.12.2009 |
|
DIN No.: |
01798377 |
|
|
|
|
Name : |
Mr. Ronald Anthony Youngs |
|
Designation : |
Director |
|
Address : |
Scarlet Oakes, Ridgway, Pyrford, |
|
Date of Birth/Age : |
08.02.1952 |
|
Date of Appointment : |
28.12.2009 |
|
DIN No.: |
02886912 |
|
|
|
|
Name : |
Mr. Anthony Edgar Butler |
|
Designation : |
Director |
|
Address : |
19, |
|
Date of Birth/Age : |
08.05.1953 |
|
Date of Appointment : |
28.12.2009 |
|
DIN No.: |
02886882 |
KEY EXECUTIVES
|
Name : |
Ms. Darshana |
|
Designation : |
Account Executive |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 25.09.2012
|
Names of Shareholders |
No. of Shares |
|
Ninad Sharad Raje |
1 |
|
GEA Process Engineering ( |
4707944 |
|
TOTAL
|
4707945 |
AS ON 25.09.2012
|
Equity Shares
Break Up |
Percentage of
Holding |
|
Bodies corporate |
100.00 |
|
TOTAL |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing of Pharma
Industrial Equipments. |
|
|
|
|
Exports : |
|
|
Countries : |
|
|
|
|
|
Terms : |
|
|
Selling : |
L/C, Cash, Credit (30 Days) |
|
|
|
|
Purchasing : |
Cash, Credit (30 Days) |
PRODUCTION STATUS (AS ON 31.03.2011)
Installed Capacity
The information pertaining to Installed Capacity is not relevant as the items
produced by the Company are of a highly dissimilar nature.
|
Particulars |
Production |
|
Bulk Milk Cooler (BMC) |
5 |
|
Fluid Bed Dryer (FBD) |
380 |
|
Pharma Connect (PMA) |
160 |
|
Vibro Fluidizer (VF) |
0 |
|
Ducting |
31 |
|
Material Handling |
33 |
|
Others |
94 |
|
|
703 |
GENERAL INFORMATION
|
Customers : |
|
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
No. of Employees : |
300 (Approximately) |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Bankers : |
Tel No.:- 91-265-2355900 / 2356000 |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Keyur Patel and Company Chartered Accountant |
|
Address : |
SF - 14, Hiravanti Chambers, Opposite Aaryakanya Vidhyalaya,
Karelibaug, Vadodara-390018, Gujarat, India |
|
Tel. No.: |
|
|
Mobile No.: |
|
|
Fax No.: |
|
|
E-Mail : |
|
|
PAN No.: |
AKVPP0199E |
|
|
|
|
Holding Company : |
GEA Process Engineering (India) Private Limited CIN No:- U74999MH1992PTC065230 |
|
|
|
|
Associates : |
v GEA
v GEA Ecoflex India Private Limited v GEA Niro-GEA Process Engg A/S v GEA Pharma Systems Limited v GEA Pharma Systems NV v GEA Process Engg (NPS) Limited v GEA Tuchenhagen GmbH v WestfaliaSurge Deutschland GmbH v WestfaliaSurge Japy SAS v GEA Pharma Systems AG v GEA IT-Services GmbH v GEA Process Engineering Pte Limited |
CAPITAL STRUCTURE
AS ON 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
5110000 |
Equity Shares |
Rs.10/- each |
Rs. 51.100 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
4707945 |
Equity Shares |
Rs.10/- each |
Rs. 47.079
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
47.079 |
47.079 |
47.079 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
130.413 |
145.600 |
232.268 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
(36.334) |
|
|
NETWORTH |
177.492 |
192.679 |
243.013 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
63.841 |
91.140 |
0.000 |
|
|
2] Unsecured Loans |
183.499 |
43.999 |
88.447 |
|
|
TOTAL BORROWING |
247.340 |
135.139 |
88.447 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
424.832 |
327.818 |
331.460 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
308.711 |
305.578 |
265.471 |
|
|
Capital work-in-progress |
0.957 |
0.446 |
21.946 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
7.811 |
14.650 |
14.651 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
127.609
|
95.370
|
63.075
|
|
|
Sundry Debtors |
135.801
|
53.568
|
31.211
|
|
|
Cash & Bank Balances |
12.814
|
8.793
|
16.040
|
|
|
Other Current Assets |
104.134
|
60.240
|
0.000
|
|
|
Loans & Advances |
24.156
|
18.460
|
20.270
|
|
Total
Current Assets |
404.514
|
236.431 |
130.596 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
150.545
|
95.899 |
53.501 |
|
|
Other Current Liabilities |
118.147
|
115.325
|
34.593
|
|
|
Provisions |
28.469
|
18.063
|
13.377
|
|
Total
Current Liabilities |
297.161
|
229.287 |
101.471 |
|
|
Net Current Assets |
107.353
|
7.144
|
29.125
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.267 |
|
|
|
|
|
|
|
|
TOTAL |
424.832 |
327.818 |
331.460 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
418.728 |
266.755 |
60.688 |
|
|
|
Other Income |
13.776 |
4.934 |
1.383 |
|
|
|
TOTAL (A) |
432.504 |
271.689 |
62.071 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Increase /Decrease is Inventories |
|
28.206 |
(24.380) |
|
|
|
Cost of Material and Other Manufacturing Expenses |
|
143.056 |
44.635 |
|
|
|
Employee Cost |
|
52.716 |
21.933 |
|
|
|
Administrative Expenses |
|
66.006 |
15.814 |
|
|
|
Selling and Distribution Expenses |
|
6.210 |
0.292 |
|
|
|
Preliminary Expenses Written Off |
|
0.134 |
0.134 |
|
|
|
TOTAL (B) |
NA |
296.328 |
58.428 |
|
|
|
|
|
|
|
|
Less |
PROFIT
/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
NA |
(24.639) |
3.643 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
NA |
12.647 |
6.891 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
5.969 |
(37.286) |
(3.248) |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
NA |
13.048 |
0.279 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
BEFORE TAX (E-F) (G) |
NA |
(50.334) |
(3.527) |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
NA |
0.000 |
(0.205) |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
AFTER TAX (G-H) (I) |
(15.187) |
(50.334) |
(3.322) |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
NA |
(36.334) |
(33.012) |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
NA |
(86.668) |
(36.334) |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Sales |
179.599 |
96.404 |
46.809 |
|
|
|
Sales Commission |
0.597 |
4.250 |
1.140 |
|
|
|
Income from Dire Services |
7.749 |
1.829 |
0.000 |
|
|
TOTAL EARNINGS |
187.945 |
102.483 |
47.949 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
79.200 |
65.578 |
10.145 |
|
|
|
Capital Goods |
2.237 |
3.343 |
0.103 |
|
|
TOTAL IMPORTS |
81.437 |
68.921 |
10.248 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
(3.23) |
(10.69) |
(7.69) |
|
Expected Sales (2012-2013) : Rs. 750.000 Millions
The above information has been parted by Ms. Darshana.
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
(3.51)
|
(18.53)
|
(5.35)
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
NA
|
(18.87)
|
(5.81)
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
NA
|
(9.04)
|
(0.89)
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
NA
|
(0.26) |
(0.01)
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
1.39
|
0.70 |
0.36
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.36
|
1.03 |
1.29
|
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
----- |
|
14] |
Estimation for coming
financial year |
Yes |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details
(if applicable) |
Yes |
|
21] |
Market information |
----- |
|
22] |
Litigations that the firm
/ promoter involved in |
----- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
----- |
|
26] |
Buyer visit details |
----- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director,
if available |
No |
|
34] |
External Agency Rating,
if available |
No |
|
UNSECURED LOAN |
Rs.
In Millions 31.03.2012 |
Rs.
In Millions 31.03.2011 |
|
Short Term
Borrowings |
|
|
|
Loans and advances from related parties |
183.499 |
43.999 |
|
|
|
|
|
TOTAL |
183.499 |
43.999 |
SUNDRY CREDITORS
DETAILS
(Rs.
In Millions)
|
Particulars |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
Sundry Creditors
|
|
|
|
|
- Micro Enterprises
and Small Enterprises |
0.000 |
0.000 |
0.000 |
|
- Others |
150.545 |
95.899 |
53.501 |
|
|
|
|
|
|
TOTAL |
150.545 |
95.899 |
53.501 |
NOTE
Registered office of the company has been shifted
from Block No.8, Village Dumad, Savali Road, Vadodara – 391 740, Gujarat, India
to the present address w.e.f. 22.07.2009.
OUTLOOK
ECONOMY
During the year 2011-12 there was slowdown in growth of Indian Economy as
it grew by 6.9% [Estimated] in 2011-12 mainly due to weakening industrial
growth which retreated significantly by 37.5%. For the current financial year,
they expect Indian Economy to grow by less than 6%.
The fiscal 2011.12 was also marked by a sharp depreciation
of the Indian rupee. On month-to-month
basis the rupee depreciated by 12.4 per cent from 44.97 per US dollar in March 2011 to 51.34 per
US dollar in January 2012. Rupee reached
a peak of 43.94 on 27 July 2011 and lowest at 54.23 per US
dollar on 15 December 2011
indicating a depreciation of 19 per cent. The Reserve Bank of India was
required to sell dollar5 twice in the fiscal to help raise the value of the
rupee. The pressure on Indian rupee is expected to continue.
Trade deficit
widened from expected USD 160
billion to USD 180 billion for
April-March 2011-12, a rise of 52% on a year on year basis. Rising
cast of oil imports due to oil prices being higher by aver 7% on a year on year
basis pushed up overall imports
by 28.5% while export growth was muted
at 17.5% leading to a surge in
trade deficit.
The slowing global
economy and the resulting nervous sentiment on the financial markets could lead to lower consumer spending and
capital expenditure projects being postponed in many cases. The company has envisaged these events
and is planning to
PHARMACEUTICALS
According to
McKinsey, the Indian Pharma Industry will grow to USD 55 Billion
by 2020 with a potential to reach US0 70
Billion in an aggressive growth scenario. Over 2009, the industry is expected to grow with a CARG at 17%
till 2020. A growth of 16.5% in 2011-12 is indicative of the built up
expectations.
A large number of
patent expirations continue to offer strong growth prospects for generic
players in the developed markets. While patent expires are expected to peak out
in 2012, they believe that the growth momentum
would sustain as most of Indian companies have a fairly well spread out product
pipeline till 2014. They have
therefore seen many large size Indian companies and MNC's undertaking expansion for building production of
drugs expiring patent. A shift to SEZ's by these companies is seen since most of
the large scale players in the industry are either suppliers to Multi Nationals
overseas or are themselves
planning a foray in developed
markets. This is adding advantage to your company which is 100% Export Oriented Unit.
OPERATIONS
The gross sales and other income for the financial year were Rs. 432.500
Millions as against Rs. 275.510 Millions for the previous financial year
registering an increase of 1.57 times. The profit before depreciation and tax
stood at Rs. 5.970 Millions against loss of Rs. 50.200 Millions recorded in
previous year. The net loss stood at Rs. 15.190 Millions (Rs. 50.330 Millions
previous year).
FIXED ASSETS
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or anti-terrorism
sanction laws or whose assets were seized, blocked, frozen or ordered forfeited
for violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 54.42 |
|
|
1 |
Rs. 83.20 |
|
Euro |
1 |
Rs. 71.90 |
INFORMATION DETAILS
|
Information Gathered
by : |
JML |
|
|
|
|
Report Prepared
by : |
DPT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
2 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
29 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.